Bavarian Nordic initiates Phase 1 clinical trial of MVA-BN RSV vaccine
18 August 2015 | By Victoria White
Bavarian Nordic has initiated a Phase 1 clinical study of its MVA-BN vaccine candidate against respiratory syncytial virus (RSV)...
List view / Grid view
News
Growth hormone deficiency treatment market value to reach $1.88b by 2024
The global market for growth hormone deficiency (GHD) treatment will rise in value from $1.26 billion in 2014 to reach approximately $1.88 billion by 2024, representing a moderate Compound Annual Growth Rate (CAGR) of 4.08%, according to research and consulting firm GlobalData.
Aspirin reduces obesity-associated cancer risk
18 August 2015 | By Victoria White
An international study of people with a family history of cancer has shown that a regular dose of aspirin reduces the long-term risk of the disease...
B-YOND study results reinforce long-term clinical profile of Alprolix
18 August 2015 | By Victoria White
Interim results from the B-YOND study support the long-term safety and efficacy of Alprolix in people with severe haemophilia B treated for up to two years...
NICE tackles overuse of antibiotics
18 August 2015 | By Victoria White
NICE, the UK health watchdog, has published guidance to help doctors, nurses and pharmacists promote and monitor the sensible use of antibiotics...
EC grants Marketing Authorisation for dinutuximab
17 August 2015 | By Victoria White
The EC has granted Marketing Authorisation for dinutuximab for the treatment of high-risk neuroblastoma in patients aged 12 months to 17 years...
Sierra Leone down to last chain of Ebola transmission
17 August 2015 | By Victoria White
An epidemiological week has now passed with no new Ebola cases in Sierra Leone for the first time since the beginning of the outbreak...
Spiolto Respimat provides meaningful quality of life improvements in COPD
17 August 2015 | By Victoria White
New data show Spiolto Respimat provides consistent, clinically meaningful improvements in quality of life versus placebo in patients COPD...
Trial of selepressin for treatment of septic shock begins
17 August 2015 | By Victoria White
Ferring Pharmaceuticals has started patient enrollment in a Phase 2b/3 clinical trial of selepressin for the treatment of septic shock...
ISS recommends Mylan shareholders vote “against” Perrigo bid
17 August 2015 | By Victoria White
The ISS has recommended that Mylan shareholders vote "against" the unsolicited offer to acquire all of the outstanding shares of Perrigo...
Diabetes cases soar in the UK
17 August 2015 | By Victoria White
The number of people living with diabetes in the UK has soared by nearly 60% in a decade, according to a new analysis by Diabetes UK...
Atezolizumab shrank tumours in people with NSCLC in PII study
17 August 2015 | By Victoria White
In Roche’s large pivotal Phase II study, BIRCH, atezolizumab met its primary endpoint and shrank tumours in people with locally advanced or metastatic NSCLC...
Roche acquires in vitro diagnostics company GeneWEAVE
13 August 2015 | By Katie Sadler, Digital Content Producer, European Pharmaceutical Review
Roche has announced the acquisition of GeneWEAVE BioSciences Inc. to strengthen its offering in the field of microbiology diagnostics.
CPhI China report predicts domestic growth to outpace exports
13 August 2015 | By CPhI China
CPhI – a division of UBM EMEA – alongside UBM Sinexpo, announces the findings of the Pharma Insights China 2015 report.
Improved membrane chromatography performance
12 August 2015 | By Sartorius
Redesigned Sartobind® membrane adsorber capsules offer higher binding capacities, reduced void volumes, less buffer consumption and lower operational costs...
